Chemical Structure (Tazicef 01)
Tazicef Injection, Powder, For Solution
Product Images NDC 0409-5093
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Tazicef (NDC 0409-5093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Tazicef 01a
Fig 1 And 2 (Tazicef 02)
Fig 3 And 4 (Tazicef 03)
Fig 5 And 6 (Tazicef 04)
Hospira Logo (Tazicef 05)
Principal Display Panel (1 gram Vial Label)
Principal Display Panel (1 gram Vial Carton)
This is a description of Ceftazidime, a medication used for intravenous infusion to treat bacterial infections. It comes in single-dose ADD-Vantage containers for adult use only. The reconstituted solution is stable for 24 hours at room temperature. It is important to store the medication at a temperature range of 20°C to 25°C before reconstitution. Each vial contains Ceftazidime at 1-gram strength per vial with additional sodium carbonate. The medication is manufactured by Sandoz GmbH for Hospira Inc. The text also includes the NDC code and prescribing information with dosage instructions.*
Principal Display Panel (2 gram Vial Label)
This is a product description for Ceftazidime, a medication used for intravenous infusion to treat bacterial infections. The medication is contained in single-dose ADD-Vantage vials that make it easy to mix with the appropriate solution and dose. The text specifies that there are 25 vials per order and the equivalent to 1-gram or gram/vial of Ceftazidime. The product is manufactured by Hospira and intended for use only under the prescription of a physician.*
Principal Display Panel (2 gram Vial Carton)
This is a prescription drug called Tazicef or Ceftazidime used for intravenous infusion only. The contents of each vial are 2 grams of Ceftazidime and 236 mg of Sodium carbonate. The drug comes in an ADD-Vantage® container and each vial contains sodium equivalent to approximately 5 mg or 23mEq per gram of ceftazidime activity. The drug is stable for 24 hours at room temperature after reconstitution, and slight yellowing does not affect potency. The recommended dosage for adults is not specified.*
Tazicef 10
This is a description of TAZICEF® a Ceftazidime injection used for intravenous infusion. It is available in single-dose ADD-Vantage® vials which are equivalent to 2 g/vial. The product is only available with a prescription. The provided text also contains product codes (NDC 0409-5003-11 and NDG 0409-5093-14) which might be useful to identify the product in a database.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
